# Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.

> **NCT05215743** · PHASE1 · COMPLETED · sponsor: **University of Chile** · enrollment: 18 (actual)

## Conditions studied

- Acute Myocardial Infarction
- Ischemia-reperfusion Injury
- Reperfusion Injury, Myocardial
- Reperfusion Arrhythmias
- Reperfusion Injury

## Interventions

- **DRUG:** Antioxidant therapy
- **DRUG:** NaCl 0.9%

## Key facts

- **NCT ID:** NCT05215743
- **Lead sponsor:** University of Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-09
- **Primary completion:** 2022-11-22
- **Final completion:** 2022-12-22
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05215743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05215743, "Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05215743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*